Inhibition of peroxidase activity and scavenging of reactive oxygen species by astilbin isolated from Dimorphandra mollis (Fabaceae, Caesalpinioideae)

Astilbin (5,7,3’,4’-tetrahydroxy-2,3-dihydroflavonol-3-ß-o-rhamnoside), a flavonoid with a large range of biological activities, was isolated from Dimorphandra mollis, a shrub common to the Brazilian Cerrado. The purpose of this study is to verify the effects of astilbin on myeloperoxidase (MPO) and horseradish peroxidase (HRP), and its antioxidant activity against hypochlorous acid (HOCl) and total antioxidant activity (TAC) by the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+). Astilbin inhibited MPO and HRP activities in a concentration-dependent relationship and effectively scavenged HOCl. The TAC by ABTS•+ of astilbin (IC50 ~ 20 mM) was higher than that of uric acid, which was used as a positive control. These data demonstrate that astilbin is a potent antioxidant and that it inhibits MPO and HRP activities efficiently.

Tratamento crônico com extrato alcoólico de Pterogyne nitens não melhora parâmetros clássicos do diabetes experimental / Continuous treatment with alcohol extract from Pterogyne nitens leaves does not alter typical variables of experimental diabetes

Tem sido atribuído ao flavonóide kaempferitrina e ao alcalóide galegina efeito hipoglicêmico. Folha de Pterogyne nitens, por conter tais compostos, poderia ser antidiabética. Assim, avaliamos o efeito do tratamento com Pterogyne nitens a ratos diabéticos sobre níveis glicêmicos e parâmetros fisiológicos. Ratos diabéticos (50 mg estreptozotocina/Kg peso) foram tratados durante 32 dias, 2 vezes ao dia, por gavagem com extrato etanólico de folhas de Pterogyne nitens (76 mg/0,5 mL glicerina 10 por cento por rato) (DTPn). Grupos diabéticos controles foram tratados com: glicerina 10 por cento (0,5 mL) (DTG), insulina (2,5 U/0,3 mL) (DTI) e água (0,5 mL) (DTA). Semanalmente determinamos: peso corporal, ingestão hídrica e alimentar, volume urinário e nível glicêmico. Os resultados dos grupos DTPn, DTG e DTA foram diferentes do DTI para todos os parâmetros, ocorrendo ganho de peso corporal e redução dos demais parâmetros no DTI. O grupo DTPn apresentou resultados semelhantes aos DTG e DTA. Através dos resultados apresentados no grupo DTI, constatamos que o modelo de estudo foi adequado. Também concluímos que o extrato vegetal e a glicerina não melhoraram e nem exacerbaram o quadro diabético. Resta a possibilidade da planta promover melhoria do diabetes com diferente: dose do extrato, via de administração ou severidade do diabetes induzido.

Kaempferitrin (a flavonoid) and galegin (an alkaloid) have been indicated as hypoglycemic agents. Leaves of Pterogyne nitens, which contain both compounds, might be antidiabetic. We therefore treated diabetic rats with these leaves to observe the effects on their glycemia and physiological variables. Streptozotocin-diabetic rats were given ethanolic extract of the leaves (76 mg in 0.5 mL 10 percent glycerol) (DTPn), twice a day by gavage for 32 days. Diabetic controls were given 0.5 mL 10 percent glycerol (DTG), insulin (2.5 U in 0.3 mL) (DTI) or 0.5 mL water (DTA). During this treatment, we measured level of glycemia, the body weight, daily food and water intake and urine volume, once each week. The results for the DTPn, DTG and DTA groups all differed significantly from these for the DTI group. The latter exhibited greater body weights and lower physiological variables and glycemia than the groups DTPn, DTG and DTA, all of which gave similar results. From the data for DTI rats, we conclude that the study model was appropriate. Therefore, the plant extract (plus glycerol) neither improved nor worsened the diabetic state of the rats. It is possible that this plant might ameliorate diabetes experimental if the dose of extract, treatment route or severity of induced diabetes were altered.

Estudo fitoquímico de goiaba (Psidium guajava L. ) com potencial antioxidante para o desenvolvimento de formulação fitocosmética / Phytochemical study of guava (Psidium guajava L. ) with potential antioxidant activity aiming at developing a phytocosmetic formulation

Considerando-se a qualidade dos fitoterápicos, é importante salientar que a preocupação com esta questão inclui rigoroso acompanhamento das diferentes etapas do desenvolvimento e produção destes produtos, desde a coleta do vegetal até a disponibilidade do produto final. Neste trabalho, foram realizados o controle da qualidade, o potencial antioxidante como também ensaios biológicos in vitro do fruto da goiabeira (Psidium guajava L.), para o desenvolvimento de uma formulação fitocosmética. Os resultados obtidos mostraram que o fruto apresenta taninos e flavonóides, bem como atividades antioxidante e antimicrobiana. A análise microbiológica não apresentou crescimento de patógenos na formulação desenvolvida entre os outros testes realizados. Destaca-se a importância do estabelecimento do controle da qualidade para as plantas, a fim de que sejam utilizadas para o desenvolvimento de uma formulação fitocosmética segura, eficaz e com qualidade.

Considering the quality of the phytotherapic products, it is important to point out that the concern with this question includes rigorous accompaniment of the different stages of the development and production of these products, since the collection of the vegetable until the availability of the end product. In this work the quality control, the antioxidant potential were performed as also biological assays in vitro of guava fruit (P. guajava L.), for the development of a phytocosmetic formulation. The results had shown that the fruit presents tannins and flavonoids, as well as antioxidant and antimicrobial activities. The microbiological analysis did not present growth of pathogens. The importance of the establishment of the quality control for the plants is relevant, so that they are used for the development of a phytocosmetic formulation considered safe, efficient and with quality.

Free radical scavenging profile and myeloperoxidase inhibition of extracts from antidiabetic plants: Bauhinia forficata and Cissus sicyoides

There is abundant evidence that reactive oxygen species are implicated in several physiological and pathological processes. To protect biological targets from oxidative damage, antioxidants must react with radicáis and other reactive species faster than biological substrates do. The aim of the present study was to determine the in vitro antioxidant activity of aqueous extracts from leaves of Bauhinia forficata Link (Fabaceae - Caesalpinioideae) and Cissus sicyoides L. (Vitaceae) (two medicinal plants used popularly in the control of diabetes mellitus), using several different assay systems, namely, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) decolorization, superoxide anión radical (0(2)•-) scavenging and myeloperoxidase (MPO) activity. In the ABTS assay for total antioxidant activity, B. forficata showed IC50 = 8.00±0.07 μg/mL, while C. sicyoides showed IC50 = 13.0±0.2 μg/mL. However, the extract of C. sicyoides had a stronger effect on 0(2)•- (IC50 = 60.0±2.3 μg/mL) than the extract of B. forficata (IC50 = 90.0±4.4 μg/ mL). B. forficata also had a stronger inhibitory effect on MPO activity, as measured by guaiacol oxidation, than C. sicyoides. These results indicate that aqueous extracts of leaves of B. forficata and C. sicyoides are a potential source of natural antioxidants and may be helpful in the prevention of diabetic complications associated with oxidative stress.

Smith-Lemli-Opitz syndrome: clinical and biochemical findings in Brazilian patients

Smith-Lemli-Opitz syndrome (SLOS) or RSH syndrome comprises multiple congenital anomalies and mental retardation. The underlying defect is a deficiency in the activity of delta7-sterol reductase, which decreases cholesterol and increases 7-dehydrocholesterol (7-DHC) levels. Our aim was to identify and evaluate the frequency of SLOS manifestations in a group of Brazilian patients. Based on our own data and those reported previously, we present a simple method that allows the estimation of probabilities favoring the diagnosis of SLOS. We evaluated 30 patients clinically and determined their plasma levels of cholesterol and 7-dehydrocholesterol. In 11 patients, the diagnosis was confirmed by ultraviolet spectrophotometry (UV). Of 19 patients with normal laboratory results, 17 showed a high probability favoring the diagnosis of SLOS. The most significant signs and symptoms observed in over 2/3 of the biochemically confirmed cases were mental retardation (10/11), delayed neuropsychomotor development (10/11), syndactyly of 2nd/3rd toes (10/11), and craniofacial anomalies including microcephaly (11/11), incompletely rotated ears (8/11), palpebral ptosis (10/11), anteverted nostrils (10/11), and micrognathia (9/11). Genital anomalies were found in all male patients (6/6).